Platform
Features
Alzprotect
Contact
Pierre Besançon, previously a Professor in Pharmacy, is the successor to former Laboratoires Delagrange. He is an experienced private investor in the field of biotech companies both in Europe and in the United States.
Azura Ophthalmics
Horizon
Cadila Pharmaceuticals Limited
CardioFocus
Bristol-Myers Squibb